Executive Summary #

Dripdok’s regenerative medicine protocols have consistently demonstrated success in reversing biological age, optimizing organ system function, and reducing the cellular pace of aging. Using advanced multi-omics profiling and DNA methylation biomarkers, our interventions have produced measurable biological age reductions and systemic health improvements across diverse patients.

The CLOSE Regenerative Index (CRI) #

At the core of our patient assessment methodology is the Cellular Resilience Index (CRI) — a proprietary marker representing the overall biological robustness of an individual. The CRI is calculated by integrating:

• Biological Age Deviation: The difference between a patient’s chronological age and their biological age
• Aging Pace (Years per Year): The rate at which the body biologically ages compared to the calendar year
• Organ System Variability: The disparity between aging trajectories across critical systems (cardiovascular, metabolic, neurological)

Key Results from Our Patient Cohort #

• Biological Age Reversal: Up to 9.7 years younger than chronological age in 12 months or less
• Optimal Aging Pace: 75% of patients achieved a cellular aging rate below 1.0 (biologically aging slower than calendar years)
• CRI Improvements: Systemic balance improvements across musculoskeletal, metabolic, cardiovascular, and inflammatory pathways

Methodology: Multi-Omics Biological Age Profiling #

Dripdok’s approach integrates DNA methylation analysis with multi-omics biomarker evaluation across 11 vital organ systems:

• Cardiovascular, Pulmonary (Lungs), Hepatic (Liver), Metabolic Efficiency
• Renal (Kidneys), Musculoskeletal Health, Immune Function, Hormonal Stability
• Hematological (Blood), Neurocognitive (Brain), Systemic Inflammation

Anonymized Patient Case Studies #

Case 1 – Female, Age 53 #

Biological Age: -9.68 years below chronological age. Musculoskeletal system aged 40.75 (12 years younger). Cellular aging pace: 0.94 years per calendar year (slower than chronological age). Targeted interventions focused on neuroinflammation, liver detoxification, and musculoskeletal peptide support.

Case 2 – Male, Age 61 #

Biological Age: -1.45 years below chronological age. Cardiovascular system younger than chronological age. Metabolic, blood, immune, inflammatory systems aging accelerated by 4-6 years. Interventions prioritized metabolic recalibration, inflammation suppression, and cardiovascular resilience.

Case 3 – Male, Age 42 #

Biological Age: -2.6 years below chronological age. Hormonal system at 35.62 years (6.6 years younger). Cellular aging pace: 0.86 years per calendar year (optimal deceleration). Proactive cardiovascular and cognitive optimization initiated.

The Dripdok Difference #

• Multi-Omics Precision Profiling: Real-time biological aging analysis across 11 organ systems
• Targeted Regenerative Protocols: Peptides, mitochondrial activators, and IV cellular therapies aligned to biomarker data
• Pace of Aging Monitoring: Cellular aging velocity assessed quarterly to confirm biological deceleration
• Expert-Driven Personalization: Programs designed by leaders in molecular biology, epigenetics, and regenerative therapy

Dripdok’s work demonstrates that biological age reversal is not theoretical — it is clinically achievable. These patient outcomes reflect our commitment to measurable health transformation, delivering real-world evidence that aging itself can be treated.